Company profile

Monte Rosa Therapeutics AG

More news about Monte Rosa Therapeutics AG

25.06.2021 15:26

Monte Rosa Therapeutics raises USD222 million in successful IPO

Financing

19.03.2021 11:09

Monte Rosa closes $95 million series C round

Financing

11.03.2021 13:40

New appointments at life sciences startups

Background

28.10.2020 15:59

Seasoned executives for startups

Background

25.09.2020 13:39

Monte Rosa Therapeutics Closes $96 Million Series B Financing

Financing

Monte Rosa Therapeutics AG

Founded
2018

Kanton
BS

Principal

Innosuisse

Swiss Venture Capital Report

Swiss Venture Capital Report

The new Swiss Venture Capital Report provides a review of the whole of 2023. In addition to investments, the report will once again include the results of a survey of Swiss investors, an overview of venture capital fundraising and a list of exits. You can download the Report in our asset section.

Register for more services

Partners

Gebert Rüf Stiftung

Swiss Entrepreneurs Foundation

UBS

Contributors

EPFL Innovation Park Foundation

IFJ

Innovaud

Kendris

Lichtsteiner Foundation

SICTIC

Startup Campus

Swiss Economic Forum

Swisscom

Swissnex

Switzerland Innovation

venturelab

W.A. De Vigier Stiftung

Supporters

Basel Area Business & Innovation

Business Angels Switzerland

ESA BIC Switzerland

StartAngels Network

Switzerland Global Enterprise

Technology Fund

Technopark Luzern

Technopark Winterthur

TECHNOPARK Zürich

University of Basel

USI Startup Centre

Supporters

Basel Area Business & Innovation

Business Angels Switzerland

EPFL Innovation Park Foundation

ESA BIC Switzerland

Gebert Rüf Stiftung

StartAngels Network

Swiss Entrepreneurs Foundation

Switzerland Global Enterprise

Switzerland Innovation

Technology Fund

Technopark Luzern

Technopark Winterthur

TECHNOPARK Zürich

University of Basel

USI Startup Centre

W.A. De Vigier Stiftung

By continuing to use this website you agree with our TERMS AND CONDITIONS